Stock Information
Neurogene Inc (NGNE)
Ticker Symbol: NGNE
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $335.25 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -1.9921
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -14.05%
Latest News
-
Which stocks are moving on Friday?
Fri, Feb 27, 2026 5:30 PM
-
Neurogene: Stock Soars On FDA Designation For Rett Gene Therapy - I'd Remain Cautious
Fri, Feb 27, 2026 3:32 PM
-
Canaccord Genuity Initiates Coverage On Neurogene with Buy Rating, Announces Price Target of $200
Fri, Feb 27, 2026 2:27 PM
-
Nasdaq Down Over 1%; Dell Shares Jump After Q4 Results
Fri, Feb 27, 2026 2:01 PM
-
Autodesk, Arlo Technologies, Beyond Meat, Netflix And Other Big Stocks Moving Higher On Friday
Fri, Feb 27, 2026 1:52 PM
-
12 Health Care Stocks Moving In Friday's Intraday Session
Fri, Feb 27, 2026 1:05 PM
-
Neurogene Stock Soars On FDA Breakthrough Tag For Rett Gene Therapy
Fri, Feb 27, 2026 9:06 AM
-
12 Health Care Stocks Moving In Friday's Pre-Market Session
Fri, Feb 27, 2026 8:05 AM
-
Why Applied Optoelectronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Fri, Feb 27, 2026 5:43 AM
-
Wondering what's happening in today's after-hours session?
Thu, Feb 26, 2026 10:00 PM
Key Financials
Financial data not available
